Skip to content
ARS Pharma
  • About Us
    • Meet Our Team
    • Careers
    • Job Openings
  • Product
    • neffy
      • neffy (epinephrine nasal spray)
      • neffyConnect
      • Prescribing information
    • Pipeline
    • Authorized distributors
  • Investors & Media
    • Events & Presentations
    • Press Releases
    • Stock Information
      • Stock Quote & Chart
      • Analyst Coverage
    • Financial Filings
      • SEC Filings
    • Corporate Governance
      • Documents & Charters
      • Board of Directors
      • Management Team
      • Committee Composition
      • Compliance Program
    • IR Resources
      • Email Alerts
    • Publications
    • Scientific Presentations
  • Community Program
    • neffyinSchools
  • Contact Us

EFACC Poster Presentation

Pharmacokinetics/pharmacodynamics after administration of ARS-1 (neffy® Nasal Spray), epinephrine auto-injector, and manual intramuscular injection.

EFACC 2023 POSTER

EFACC 2023 FULL POSTER MANUSCRIPT

Product is for Investigational Use; neffy is the proposed trade name, not yet FDA approved, and might change.

©2026 ARS Pharmaceuticals Operations, Inc.  All rights reserved.  “ARS Pharma,” the ARS Pharma logo design, “neffy,” the neffy logo, and the neffyconnect logo are trademarks or registered trademarks of ARS Pharmaceuticals Operations, Inc. Generic references to ARS Pharma refer to ARS Pharmaceuticals, Inc. (Nasdaq: SPRY) and/or its wholly-owned operations subsidiary.

Privacy Policy  |  Terms of Use

This site is intended for U.S. visitors only.

Login